Diabetes

Papers
(The median citation count of Diabetes is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
1151-P: Differential Associations between Plasma Lipids and Insulin Resistance in Women with and without Type 1 Diabetes94
252-OR: Virtual Multidisciplinary Lifestyle Intervention Is as Effective as the Physical Program for Patients with Diabetes and Obesity during COVID-19 Pandemic79
935-P: Favorable Shift in CGM Glucose in Youth with T1D during COVID-19 Pandemic75
31-OR: ACSL1 in Smooth Muscle Cells Regulates High-Fat Diet-Induced Obesity and Thermogenesis in Mice55
92-OR: Increased Disease Detection, Yet Treatment Barriers Identified, with Point-of-Care Retinopathy Screening52
962-P: Plasma Beta Hydroxybutyrate in Pregnancy and Gestational Diabetes52
1159-P: One-Hour Glucose during Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse in Black Obese Patients with Hyperglycemic Crises51
619-P: Comparison of Dexcom G6 Continuous Glucose Monitoring and Point-of-Care Blood Glucose Testing in Hospitalized Patients with Diabetes51
1152-P: Elucidating Protective Mechanisms of Targeting of hOGG1 to Mitochondria on the HFD-Induced Insulin Resistance in Mice Lacking OGG146
Adipocyte-Derived Extracellular Vesicles: Caveolin Matters43
Deoxysphingolipids – atypical skeletal muscle lipids related to insulin resistance in humans that decrease insulin sensitivity in vitro43
1278-PUB: Acid-Base Alterations after Isotonic Fluid Resuscitation of Patients in Suspected DKA in the Pediatric Emergency Department42
545-P: Experiences of Emerging Adults with T1D during the COVID-19 Pandemic42
797-P: Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-WECAN Study40
201-OR: Remission of Type 2 Diabetes and Decreased Inflammatory Markers with a High-Protein Diet40
1239-P: Evidence of Altered Alpha- and Beta-Cell Lysosomes prior to Onset of Type 1 Diabetes40
363-P: The Ceramide- and Phosphatidylcholine-Based Coronary Event Risk Test 2 (CERT2) and Cardiovascular Mortality in Men and Women with Type 2 Diabetes39
145-OR: Annual Wellness Visits Are Associated with Increased Use of Diabetes Preventive Services in the Diabetes Belt and Surrounding Counties39
1181-P: Consumption of Naturally Enriched Complex Carbohydrate Meal Improves Insulin Sensitivity and Disposition Index in Type 2 Diabetes39
778-P: SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors and Risk of All-Cause Hospitalization39
389-P: Pathological Significance of Renal Tubular ROCK2 in Chronic Kidney Disease38
607-P: Glycemic Metrics in Japanese Flash Glucose Monitoring Users by Diabetes Type and Therapy38
101-OR: Efficacy and Safety of Once-Weekly Semaglutide 2.0 vs. 1.0 mg for Type 2 Diabetes: SUSTAIN FORTE Randomized Trial37
910-P: Psychosocial Characteristics Associated with Diabetes Device Use in Teens with T1D36
203-LB: Boosted Beta-Cell Function with Selective Deletion of the Adaptor Protein Mig636
163-LB: Differences in Maternal and Fetal Outcomes by CGM Use in a T1D Specialty Clinic35
The Complexities of Intestinal Lipoprotein Production in Insulin Resistance and Diabetes: Revisiting a 2010 Diabetes Classic by Pavlic et al.35
639-P: GIP Receptor Agonism Enhances Weight Loss from Either a Biased or an Unbiased GLP-1 Receptor Agonist in DIO Mice34
923-P: CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Insulin Lispro Increases Time in Range Compared with Standard Insulin Lispro in Adults with Type 1 Diabetes—A Double-Blind, Randomized, Crossover S34
Regulatory T Cells Control Effector T Cell Inflammation in Human Prediabetes33
204-OR: An Early Immune Signature in Prediabetes Can Predict Progression to Type 2 Diabetes33
Protective Renalase Deficiency in β-Cells Shapes Immune Metabolism and Function in Autoimmune Diabetes32
246-OR: Probing the Role of Alternative Splicing of IKZF1 in Risk for Type 1 Diabetes31
Issues and Events30
Sorting Out the Receptor Isoforms Underlying Dopamine Inhibition of Insulin Secretion30
Comment on Colclough et al. and Saint-Martin et al. Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young. Diabetes 2022;71:29
Response to Comment on D’Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800–180629
Issues and Events29
Issues and Events29
Annexin 1 Mimetic Ac2-26 Holds Promise for the Treatment of Diabetic Nephropathy29
Issues and Events29
Issues and Events28
Issues and Events28
A Special Thanks to the Reviewers of Diabetes28
153-OR: Measurement of C-Peptide at Diagnosis Informs Glycemic Control but Not Hypoglycemic Risk in Type 1 Diabetes27
931-P: Supporting Physical Activity in Children with Type 1 Diabetes: A Survey of Health Care Professionals27
507-P: Effectiveness of a Ketogenic Diet and Virtual Coaching Intervention for Patients with Diabetes: A Difference-in-Differences Analysis27
1169-P: PNPLA3 148M Is More Susceptible to PA-Induced Endoplasmic Reticulum Stress-Associated Apoptosis in HepG2 Cells27
865-P: Care Management Processes That Improve Diabetes Outcomes26
458-P: The Current Status and Influencing Factors of In-Home Handling of Disposable Needles among Diabetic Patients in Beijing26
1410-P: Impacts of COVID-19 on Underserved Communities with Diabetes25
29-LB: Exercise Effects on ?3-AMPK Activity, Akt Substrate of 160 kDa Phosphorylation, and Glucose Uptake in Muscle of Normal and Insulin-Resistant Female Rats25
1451-P: Peri-Islet Fibrosis in Cystic Fibrosis Is Associated with Altered Alpha-Cell Phenotype25
733-P: Diabetes Remission Outcomes Protocol (DROP)—Early Observation25
699-P: Neighborhood Disadvantage and Psychosocial Health for Parents of Teens with Type 1 Diabetes (T1D)25
968-P: Cardiovascular Risk Management in the Elderly: A Nationwide Register Study of Discontinuation Patterns Prior to Death25
1319-P: Vascular Multimorbidity in Danish Persons with Type 2 Diabetes Is Decreasing, Contributing to Mortality Decline25
1544-P: Circadian Timing of SGLT2 Inhibitor Administration Modulates Therapeutic Effects on Pancreatic Islet Function, Composition, and Gene Expression25
800-P: Predictors of HbA1c and dTIR Responses with iGlarLixi in Type 2 Diabetes—Patient-Level Exploratory Analyses of the LixiLan-L Trial25
562-P: Transition of Care in Type 1 Diabetes and Association with Student and Employment Status25
Natural Protection From Type 1 Diabetes in NOD Mice Is Characterized by a Unique Pancreatic Islet Phenotype25
507-P: Trajectories of Inflammatory Proteins over Diabetic Wound Healing Course24
1639-P: Meroterpenoid-Rich Fraction of the Ethanol Extract from Sargassum Serratifolium Suppressed Muscle Atrophy Induced by Dexamethasone in C2C12 Myotubes and C57BL/6 Mice24
1844-PUB: What Impacts Stress Coping Ability in Type 2 Diabetes When It Is Measured by Japanese Method—A Cross-Sectional Study24
1640-P: Meroterpenoid-Rich Ethanolic Extract of Sargassum serratifolium (MES) Alters Macrophage Transcriptome and Secretion Profile toward Improving Muscle Atrophy and Glucose Intolerance24
1819-PUB: Multicentric Real-World Evaluation of CGM Metrics across Urban and Semi-urban Dedicated Diabetes Care Centres in 887 T2DM24
1807-PUB: Monocarbonyl Curcumin Analogs C66 and B2BrBC Improve Redox Status in Streptozotocin-Induced Diabetic Rats23
53-LB: Do the Right Thing—Intensive Intervention and Resulting Costs for Youth with High Social Risk and Type 1 Diabetes (T1D)23
1811-PUB: Real-World Safety of the Combined Use of Dapagliflozin and Metformin in Type 2 Diabetes Mellitus Patients in China—Post Hoc Analysis of the DONATE Study23
1494-PUB: Variable Responses to GLP-1 Receptor Agonists22
197-LB: The Regulation of HSL by Macrophage Migration Inhibitory Factor (MIF) Contributes to Adipocyte Hypertrophy and Development of Obesity22
1489-PUB: Know Diabetes by Heart Campaign and Project Dulce: A Culturally Tailored Mobile-Based Self-Management Program Supports High-Risk Populations with Diabetes to Manage Cardiovascular Disease Ri22
1492-PUB: In Silico Modeling of the Performance of a Novel Closed-Loop Algorithm Using the UVA/PADOVA Type 1 Diabetes Simulator22
1486-PUB: Single-Toe Necrosis over Diabetic Foot Ulcer (DFU) : Amputation Surgery at Bedside by a Diabetologist or in the Operating Room by a Surgeon22
1481-PUB: Gliclazide vs. Linagliptin on the Incidence of Hypoglycemia and Major Adverse Cardiovascular Events in Adults with Type 2 Diabetes: Narrative Synthesis of Systematic Literature Search21
515-P: The Impact of COVID-19 Worries on Diabetes Distress and Depressive Symptoms in Older Adults with Type 2 Diabetes21
1482-PUB: Insulin Receptors in Vascular Smooth Muscle Cells Regulate Plaque Stability by Its actions on Glycolysis and Oxidative Phosphorylation21
155-OR: Diabetes Complications and Cognitive Function in Youth with Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth Study21
7-LB: Lowering of Blood Pressure and Pulse Rate by Switching from DPP-4 Inhibitor to Luseogliflozin in Patients with Type 2 Diabetes and Hypertension: A Multicenter, Prospective, Randomized, Open-Labe21
1488-PUB: Did New York City Diabetes Prevention Programs Suffer or Succeed during COVID-Pandemic Lockdowns?21
486-P: Does Racial Homogeneity within an Organization Affect Non-Hispanic Black Participant Performance Outcomes in the National Diabetes Prevention Program (National DPP)21
174-LB: Severe Hypoglycemia, High Anxiety, and Depressive Symptoms Are Associated with Erectile Dysfunction in Male Adults with Type 1 Diabetes in a Brazilian Tertiary Hospital20
409-P: Arteriolar Hyalinosis Is Associated with the Rate of eGFR Decline and Predicts the Onset of Macroalbuminuria and eGFR<60 Ml/min/1.73 M2 in Patients with Type 2 Diabetes and Normo-microal20
792-P: Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study20
89-OR: Cardiovascular and Mortality Risk with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Inhibitors in Patients with Diabetic Retinopathy (DR)20
721-P: Efficacy and Safety of Basal-First Titration Order in Patients with Type 2 Diabetes (T2D) Receiving Short-Term Intensive Insulin Therapy (SIT)20
543-P: Challenges in Glucose Management in Young Adults during the COVID-19 Pandemic20
454-P: Pharmacist-Led Diabetes Self-Management Education and Reduction of Readmission Rates at a County Hospital19
1287-PUB: SGK1-NDRG1 Signal Axis as a Key Marker Associated with Insulin Resistance and Impaired Incretin Profile in Subcutaneous and Omental Fat Depots among Obese Patients19
714-P: Assessment of the Patient Transition Experience to Hybrid Closed-Loop Insulin Pump Therapy19
1002-P: Implementing Continuous Glucose Monitoring in Children with Type 2 Diabetes19
1087-P: Therapy Trends at One Year in the Longitudinal LANDMARC Study on Real-World Outcomes in Type 2 Diabetes Patients in India19
244-OR: Toward Improved Identification of Adult-Onset Type 1 Diabetes (T1D): Clinical Characteristics Associated with T1D Polygenic Risk Scores in the Million Veteran Program (MVP)19
307-OR: Mean Blood Beta-Hydroxybutyrate Predicts Clinically Significant Weight Loss following 90 Days Carbohydrate-Restricted Nutrition Therapy19
684-P: Tracking Type 2 Diabetes Progression Using CGM Systems19
327-OR: Multicountry Analysis of Trends in All-Cause Mortality among People with Type 1 Diabetes19
267-OR: Assessing Patient Knowledge about Diabetic Foot Ulcer Offloading19
1301-P: The Effect of Insulin on α-Aminoadipic Acid Metabolism in Polycystic Ovary Syndrome (PCOS) Patients with Insulin Resistance19
729-P: Efficacy and Safety of Mylan Insulin Glargine Products (MYL-1501D) from Two Manufacturing Processes (Process V and Process VI) in Combination with Insulin Lispro in Subjects with Type 1 Diabete19
1148-P: Risk Factor Control and Risk of Hospitalization for Heart Failure in Diabetic Patients18
690-P: Deterioration in Glycemic Control on School Days among School-Aged Children with Type 1 Diabetes: A Continuous Glucose Monitoring–Based Study18
35-OR: Multicenter MRI Assessment of the Pancreas in Type 1 Diabetes (MAP-T1D) Predicts Progression of Type 1 Diabetes18
893-P: Incremental Health Care Utilizations and Medical Expenditures Associated with Cognitive Impairment among Older Adults with Diabetes18
1320-P: Insulin Receptors and Their Signal Transduction Pathways in Choroid Plexus18
258-OR: Sustainability of HbA1c Control of Tirzepatide vs. Insulin Glargine in People with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)18
255-LB: Defining Functional Phenotype in Human Islets across Endocrine Cell Composition, Donor Age, Sex, and Ancestry18
194-OR: The Effect of Level of Spinal Cord Injury on the Prevalence of Diabetes18
611-P: Do Social Needs Impact Quality of Life among Adult Medicaid Beneficiaries with Type 2 Diabetes?17
1407-P: Deletion of the Abi3 Immune Gene Locus in Mice Results in Obesity and Systemic Metabolic Disruption17
160-LB: Age-Related Adipose Tissue Fibrosis and Neuropathy in the Genetically Diverse HET3 Mouse17
205-LB: ERK Is Required for LPS-Induced TLR4 Internalization in Macrophages17
901-P: Population Characteristics and Spending Patterns of High-Expenditure Patients among Medicare Beneficiaries with Diabetes17
175-LB: Patient Determinants of Mortality with Severe DKA and/or HHS during the COVID Pandemic Differ from the Prepandemic17
308-OR: The Circadian Clock Exerts Coordinated Control of Beige Adipocyte Development via Cytoskeleton-MRTF/SRF Signaling Cascade17
1060-P: Exploring Differences in the 24-Hour Glucose Cycle by Physical Activity Level in Women with Pregnancy Hyperglycemia17
1062-P: Outcomes in Pregnancies with Preexisting Type 1 Diabetes vs. Healthy Controls over a 14-Year Period17
202-OR: Early De Novo DNA Methylation Patterning Regulates Adult Beta-Cell Function and Survival Programs17
1046-P: Role of Serum C1q/TNF-Related Protein 9 in Predicting Gestational Diabetes Mellitus17
560-P: Medical Nutrition Therapy Treatment for Gestational Diabetes17
24-OR: Podocyte Targeted Pyruvate Kinase M2 (PKM2) Activation Normalized Glomerular VEGF Expression, Mitochondrial Function, Fuel Metabolism, and Diabetic Nephropathy17
607-P: Gender Differences in the Relationship between Financial Barriers and Emergency Department Visits due to Diabetes16
396-P: Real-Life Evaluation of Sodium–Glucose Cotransporter 2 Inhibition in Type 1 Diabetes16
442-P: Sorbs2 Deficiency–Mediated Vascular BK Channel Dysfunction in Type 2 Diabetes16
582-P: Process Evaluation of Dulce Digital–Me: An Adaptive mHealth Intervention for Underserved Hispanics with Diabetes16
302-OR: Hypoimmune Human Primary Pancreatic Islets Survive and Function in Humanized Diabetic Mice16
819-P: Long-Term Testosterone Treatment Improves Liver Function Parameters in Men with Hypogonadism and Type 2 Diabetes Mellitus: Real-World Data from a Registry16
377-P: Exercise-Related Hypoglycemia Induces Hypercoagulable Changes in Patients with Type 1 Diabetes16
1397-P: A Cocoa Butter–Based Ketogenic Diet Fails to Improve Glucose Homeostasis and Promote Weight Loss in Obese Mice16
25-LB: Peripheral Neuropathy and Associated Factors in Patients with Type 2 Diabetes Mellitus in Vietnam—A Cross-Sectional Study16
834-P: Two-Year Effects of Carbohydrate-Restricted Nutrition Therapy Delivered via Continuous Remote Care among Veterans with Type 2 Diabetes: A Nationwide, Real-World Study16
57-LB: Evaluating the Receptiveness to Wear Flash Glucose Monitoring System (FGMS) Sensors in People with Prediabetes—A Feasibility and Acceptability Study16
1197-P: The Demographic and Geographic Distribution of Diabetes and Prediabetes Risk in Rural Settings16
408-P: Fibrosis 4 Index Related to Microalbuminuria in Tibetan Patients with T2D and NAFLD16
996-P: Systolic Blood Pressure (BP) Is Associated with Carotid Intima-Media Thickness (CIMT) Independently of Type 2 Diabetes Predisposition in Minority Children15
1249-P: How Can Serum Adiponectin Levels Be Evaluated in Clinical Settings?15
1137-P: Continuous Glucose Monitoring (CGM) Use and Its Impact on Glycemic Control and Acute Complications among Older-Onset Type 1 Diabetes Patients within the Veterans Health Administration (VHA)15
1384-P: Serum Fibroblast Growth Factor 1 Levels and Its Association with ß-Cell Function and Insulin Sensitivity in Adults with Glucose Intolerance15
1038-P: Exposures to Hyperglycemia in the Embryonic Period and to Breast Milk from Mothers with Hyperglycemia Affect Glucose Tolerance with Higher Glucagon-Like Peptide-1 Secretion15
231-LB: GLP-1 Promotes Cortical and Medullary Perfusion in Human Kidney and Maintains Tissue Oxygenation during Na Loading15
1190-P: Oral Health Status among U.S. Adults with and without Diabetes, 202015
1175-P: Association between Equol-Producer and Type 2 Diabetes Mellitus in a Japanese Elderly Population15
324-OR: Pathway-Specific Role of Insulin in an In Vivo Model of Restenosis15
226-LB: Genetic Variation of Human Myokine Signaling Is Dominated by Biologic Sex and Sex Hormones15
728-P: Glycemic Variability of Tirzepatide vs. Insulin Degludec in People with Type 2 Diabetes Using Continuous Glucose Monitoring (SURPASS-3 CGM)15
1020-P: Racial Disparity in Glycemic Outcome during Real-World Use of an Advanced Hybrid Closed-Loop System (AHCL) among Youth with Type 1 Diabetes (T1D)15
804-P: Barriers and Concerns Regarding Initiating Insulin Therapy among People with Type 2 Diabetes15
965-P: Factors Associated with Poor Glycemic Control in Persons with Type 2 Diabetes and Employer-Based Health Care Coverage15
31-OR: Almond Milk Has No Additional Benefits over 2% Milk on Postprandial Glycemia, Lipidemia, and Gastrointestinal Hormones in Patients with Type 2 Diabetes15
346-OR: Race/Ethnicity-Specific Relationships of Physical Markers of Adiposity to Clamp-Measured Insulin Sensitivity (IS) and ß-Cell Function (ßCF) in Obese Youth14
157-LB: Scanning Frequency and Glucose Variability in the First Trimester of T1DM Pregnancies Predict Time Spent in Very Low Glucose Range in the Last One—Analysis of Intermittently Scanned Continuous14
921-P: Diabetes Preventive Care for Medicare Beneficiaries: Comparing Efficiency between the Diabetes Belt and Surrounding Areas14
125-LB: Individualized Cost-Effectiveness Assessment of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) vs. Sulfonylureas as Add-On Therapy in People with Inadequately Controlled Type 2 Diabetes (T14
1045-P: Relative Cord Hyperleptinaemia Is Associated with Higher Cord C Peptide and Lower Birthweight in Male but Not Female Neonates Born to Overweight/Obese Women14
661-P: Use of a Sequential Continuous Glucose Monitoring with or without Exercise Tracker on Glycaemic Control in Middle-Aged Patients with Diabetes Mellitus14
380-P: Burden of Low Interstitial Fluid Glucose Levels among Type 2 Diabetes Patients with Chronic Kidney Disease and Its Associated Variables14
170-OR: Outcomes of a Digital Health Coaching Program Integrating Food Delivery for a Population of Adults with T2DM at Risk of Food Insecurity14
383-P: Clinical Practice Gap Analysis of Severe Hypoglycemia Assessment and Treatment in Patients with Diabetes14
1426-P: Increased Insulin Secretion and Glucose Effectiveness Result in Improved Glucose Tolerance in Obese Subjects Two Months after Gastric Bypass and Sleeve14
1136-P: A Population-Based Assessment of the Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and Peptidomimetic Dipeptidyl Peptidase-4 Inhibitors14
1035-P: Early Pregnancy Alterations in the Metabolome of Obese Women14
1452-P: PDX1 and CKas Markers of Cell Maturation in the Human Pancreas14
495-P: Fully Immersive Virtual Reality Improves Empathy towards People with Diabetes14
574-P: Meta-analysis Shows Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes14
502-P: Increasing Provider Referrals to Diabetes Self-Management Education and Support Services: Recommendations from Virtual Focus Groups with Providers in New York State14
1387-P: Impacts of Androgen-Deprivation Therapy on Glucose Metabolism14
473-P: Correlation between Serum Elabela and Type 2 Diabetic Retinopathy14
570-P: Household Food Insecurity, Stress, and Anxiety among Youth and Young Adults with Diabetes14
45-LB: A Qualitative Study to Understand Why People Living with Obesity and General/Family Practitioners Experience Therapeutic Inertia in Obesity14
1034-P: No “Honeymoon” for Youth, in Particular Blacks, Diagnosed with Diabetes during the First Year of the COVID-Pandemic14
591-P: Green Diabetes: What Do People with Diabetes Think about Packaging Waste and Sustainability?14
1235-P: A Prospective Characterization of Metabolic and Metabolomic Profiles of COVID-19–Associated New-Onset Diabetes Patients Presenting with DKA from India13
1351-P: Molecular Pathogenesis of NASH through the Dysregulation of Metabolic Organ Network in the NASH-HCC Model Mouse Treated with Streptozotocin, High-Fat Diet13
987-P: Cost-Effectiveness of a Diabetes Prevention Program among Latino Youth with Prediabetes13
1223-P: CRP-Mediated Associations of the Individual and Neighborhood Stressors with T2D in the MESA Cohort13
799-P: Cognitive Assessment in Elderly with Type 1 Diabetes Mellitus on Insulin Pump: A Cross-Sectional Observational Study13
331-OR: Gestational Diabetes Knowledge Improves with Interactive Online Training Modules13
1095-P: Clusters of Prediabetes and Type 2 Diabetes Stratify All-Cause Mortality in a Cohort of Participants Undergoing Invasive Coronary Diagnostics13
456-P: HMGB1 Inhibition Protects Schwann Cells from High Glucose–Induced Cytotoxicity13
541-P: Patterns of Physical Activity and Cardiometabolic Risk in Hispanic/Latino Adults with or Vulnerable to Type 2 Diabetes13
217-LB: Hepatic Mig6 Ablation Restores Glucose Homeostasis during Diet-Induced Obesity and Aging13
50-LB: Perceived Control over Eating Improves following Initiation of Carbohydrate-Restricted Nutrition Therapy in a Continuous Remote Care Model13
752-P: Study Design and Baseline Profile for Patients with Type 2 Diabetes in the Semaglutide Once-Weekly Randomized Pragmatic Trial (SEPRA)13
1127-P: Diabetes Risk in Marginalized Urban Settings in Mexico City12
886-P: Development and Validation of the Diabetes Outcome Model for the U.S. (DOMUS)12
588-P: Examining Psychosocial and Comorbidity Factors Associated with Diabetes Distress among Medicaid Beneficiaries12
265-OR: Impact of the COVID-Pandemic on Diabetes Screening from 20to 2021 in Ontario, Canada12
402-P: Machine Learning Approach to Evaluate the Prospective Kidney Failure Risk of the Complement Proteome in T1D12
88-LB: Safety, PK, PD, and Efficacy of Weekly Dosing Supaglutide in Patients with T2D12
536-P: Impact of Physical Activity (PA) and Macronutrient Intake on CGM Glucometrics in Youth with T1D12
63-LB: Correlates of CGM Uptake among Adults with Type 2 Diabetes in Primary Care12
79-OR: Conventionalization from Cecal Transplant Recipients Protects Against Type 1 Diabetes Development in Germ-Free NOD Mice12
182-OR: Clinical Effects of SGLT2 Inhibitors in HNF1A-Diabetes (MODY3) : A Case Series12
1174-P: A Posteriori Dietary Patterns and Insulin-Resistance Status and Diabetes Risk by Hispanic/Latino Heritage in HCHS/SOL12
42-LB: Distress in Living with Diabetes Links to Age, Sex, Weight, and Good Glycaemic Control12
1050-P: COVID-Severity and Diabetes in Pregnancy12
187-OR: Declines in ß-Cell Glucose Responsiveness Correlate with Loss of Glucose Metabolism during T1D Pathogenesis12
935-P: Impact of Social Determinants of Health (SDoH) on Participation in a Remote Monitoring Diabetes Program (RDMP) to Improve Glycemic Control12
229-LB: G6PC2, a GWAS Locus for Fasting Glucose and HbA1c, Regulates Glucose-Suppression of Glucagon Secretion in a-Cells12
478-P: GALNT2 Variant Associates with Increased ANGPTL3 Circulation Level and Obesity12
791-P: Clinical Data of a New Insulin Micropump System in Children with Type 1 Diabetes Mellitus (T1DM)12
774-P: Impact of Transition to Tandem Control-IQ on Sleep Awakenings in Youth with Type 1 Diabetes (T1D) and Their Parents12
398-P: KIM-1 and TNFR 1 and Associations with Early Diabetic Nephropathy Histology11
97-LB: The DERMIS Study—Preliminary Evaluation of Skin Changes at Continuous Subcutaneous Insulin Infusion (CSII) Sites in Type 1 Diabetes (T1D)11
978-P: Rare Variants in Melanocortin 4 Receptor Gene (MC4R) Are Associated with Increased Visceral Fat and Altered Glucose Metabolism Independent of the Effect of Obesity in Children11
1442-P: Association of Elevated Serum FABP1 with Hyperuricemia in Patients with Obesity and the Alteration after Sleeve Gastrectomy11
1379-P: Combination of FGF21 and ß3-Adrenergic Treatment in Obese Mice11
26-LB: Risk Factors of Retinal Oxygen Metabolism and Hemodynamics for Retinopathy in Diabetes11
168-LB: Presentation of New Onset Diabetes in Youth during the COVID-19 Pandemic11
44-LB: Evaluating the Effectiveness of a Novel Form of Online Cognitive Behavioural Therapy for Patients with Type 2 Diabetes and Comorbid Anxiety or Depression11
1456-P: Molecular Architecture of AR Action in Insulin Secretion in Male Pancreatic ß-Cells11
93-LB: A Randomized Clinical Trial of Safety, Pharmacokinetics, and Pharmacodynamics of Weekly Dosing Supagutide in Healthy Chinese Subjects11
404-P: Relationships among Triglyceride (TG) Concentrations across Lipoprotein Subclasses, Intraglomerular Hemodynamics, and Kidney Oxygen Availability in Adolescents with Type 1 Diabetes (T1D)11
143-OR: Mapping Genetic Determinants of Blood Glucose Control in the Action to Control Cardiovascular Risk in Diabetes Study Group (ACCORD)11
982-P: Perfect Storm in Mississippi: High Rate of Obesity Leading to Surge in Pediatric Diabetes during the COVID-Pandemic11
146-OR: Loss of Hydroxycarboxylic Acid Receptor 2 (HCA2) Affects Adipose Tissue Homeostasis in a Sex-Specific Manner during Prolonged Fasting11
169-LB: Structural Echocardiographic Abnormalities in T2D —Mexico Cohort of Take Care of Me Program11
879-P: Effect of Combined SGLT2 Inhibitor and DPP-4 Inhibitor Therapy on the Production of Advanced Glycation End Products11
263-OR: Glycemic Gap Predicts Mortality in a Large Multicenter Diabetes Cohort Hospitalized with COVID-1911
827-P: 2022 Update on the BCG Clinical Trial Programs in Advanced Type 1 Diabetes11
634-P: Transition Readiness Variables Predict Transfer to Adult Care among Youth with Type 1 Diabetes11
676-P: Difference in CGM Estimated Hemoglobin A1c in Adults with Type 1 and Type 2 Diabetes11
29-LB: Investigating the Molecular Basis of the Microbiota-Mediated Regulation of Postprandial Chylomicron Production10
242-OR: Bilateral Dorsolateral Prefrontal Cortex High-Definition Transcranial Direct-Current Stimulation (HD-tDCS) Improves Time-Trial Performance in Elite Cyclists with Type 1 Diabetes (T1D)10
1322-P: Role of Macrophage NOD1 in Fat-Induced ß-Cell Dysfunction10
946-P: Multicenter Quality Improvement Project: Increasing Depression Screening across Six Pediatric Endocrinology Centers in the U.S.10
1298-P: Metabolic Clearance of Insulin Is Altered after Gastric Bypass and Sleeve Gastrectomy10
664-P: Success of Interactive, Online Education Related to Interpretation and Application of AGP Data10
174-OR: Identify Effect Modulators of Intensive Glucose Control in Preventing Cognitive Function Decline among Individuals with Type 2 Diabetes: A Revisit to the ACCORD MIND Trial10
1078-P: Elderly Patient with DM2 during the COVID-Pandemia: Forgotten but Good Glycemic Control10
1074-P: Variation in Predicted Fracture Risk by Diabetes and Obesity Status in Older U.S. Asian and White Women10
193-LB: Differentiation of PTPN2 Knockout Pluripotent Stem Cells into Stem-Cell–Derived ß-Like Cells Leads to Increased Stimulation of Diabetogenic TCR T Cell Transductants10
1214-P: Use of American Heart Association’s “Life's Simple 7” as a Predictor for Initiation of Dialysis10
1163-P: Prognostic Factors in Type 2 Diabetic Patients Diagnosed with COVID-in a Latin American Hospital10
1012-P: Neighborhood Disadvantage, Childhood Opportunity Index, and Glycemic Control for Children with Type 1 Diabetes?10
993-P: Cell-Free DNA Methylation as a Biomarker of Islet-Cell Death in Youth with Type 2 Diabetes10
1271-P: The Gut Microbiota Related Genetic Variant at ABO Locus, Circulating Metabolome, and Type 2 Diabetes Risk: Prospective Study in UK Biobank10
271-OR: Hepatic Glucagon Resistance in Mice with Nonalcoholic Fatty Liver Disease10
447-P: C/EBPß-Lin28a Positive Feedback Loop Mediated by C/EBPß Hypomethylation Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells in Restenosis10
233-LB: Ranolazine Fails to Improve Glycemia in Obese Liver-Specific Pyruvate Dehydrogenase–Deficient Mice10
1358-P: Small Intestinal Casein Sensing Regulates Food Intake and Glucose Tolerance in Rats10
704-P: Time in Range and Time Below Range in Insulin-Treated Older Adults with Type 2 Diabetes9
1142-P: In-Hospital Hyperglycemia: An Independent Marker for In-Hospital Health Care-Associated Infection and Acute Kidney Injury in Patients with and without Known Diabetes: The DINGO Study9
642-P: Physicians' Knowledge and Attitudes of Disordered Eating Behaviors among Patients with Diabetes9
74-LB: Real-World Glycemic Outcomes in Adult Patients with Type 1 Diabetes Using a Real-Time Continuous Glucose Monitor Compared with an Intermittently Scanned Glucose Monitor and Self-Measured Blood 9
708-P: Hypertension Control among People with Diabetes Using a Self-Management Multicondition Digital Platform9
239-OR: Physical Activity, Hypoglycemia, and Type 1 Diabetes: A Data-Driven Approach9
388-P: Renal ROCK2 Activity in Folic Acid-Induced Nephropathy9
103-OR: Coronary Plaque and Stenosis across Glycemic States among Asymptomatic Adults: The Miami Heart Study at Baptist Health South Florida9
1289-P: Role of Metformin and Lifestyle Modification in Management of Latent Autoimmune Diabetes in Adults9
650-P: Artificial Intelligence and Individualized Optimal Glycemic Target in ICU Patients9
0.06124210357666